The citric acid cycle (CAC), also known as the tricarboxylic acid (TCA) cycle, is a crucial metabolic pathway that plays a significant role in energy production and metabolic homeostasis. Dysfunction in this cycle can lead to a variety of diseases, primarily due to its impact on mitochondrial function and energy metabolism.
Mitochondrial dysfunction is a common feature in many diseases, including neurodegenerative disorders, cardiovascular diseases, and metabolic syndromes. The CAC is integral to mitochondrial function, and its impairment can lead to reduced ATP production and increased oxidative stress, contributing to disease pathology.
In Alzheimer's disease (AD), significant reductions in the activities of key TCA cycle enzymes have been observed. For instance, studies have reported a 57% decrease in Ξ±-ketoglutarate dehydrogenase activity and a 41% decrease in pyruvate dehydrogenase complex activity in the brains of AD patients, correlating with clinical dementia ratings. This suggests that TCA cycle dysfunction may contribute to the energetic deficits observed in AD, leading to synaptic dysfunction and neuronal death
In nondiabetic chronic kidney disease, alterations in the citric acid cycle have been documented, indicating a common phenomenon of mitochondrial dysfunction. Metabolomic studies have shown significant impairments in the CAC, suggesting that targeting mitochondrial metabolism could lead to new therapeutic strategies for CKD .
In pulmonary arterial hypertension (PAH), mitochondrial dysfunction has been implicated in the pathogenesis of the disease. A study identified significant alterations in the CAC, with specific metabolites such as citric acid showing differential expression in PAH patients compared to controls. This suggests that CAC dysfunction may contribute to the metabolic reprogramming observed in PAH .
In cancer, alterations in the CAC are often observed, with many tumors exhibiting a shift towards aerobic glycolysis (the Warburg effect) while still relying on TCA cycle intermediates for biosynthesis. This metabolic reprogramming is crucial for supporting rapid cell proliferation and survival in the tumor microenvironment .
Overall, the implications of citric acid cycle dysfunction are profound, affecting energy metabolism and contributing to the pathogenesis of various diseases, including neurodegenerative disorders, chronic kidney disease, pulmonary hypertension, and cancer. Understanding these connections may provide insights into potential therapeutic targets and strategies for intervention.